Valproic acid improves the efficacy of oxaliplatin/fluoropyrimidine-based chemotherapy by targeting cancer stem cell via β-Catenin modulation in colorectal cancer
Abstract Despite advances in systemic therapeutic approaches, metastatic colorectal cancer (mCRC) patients harboring BRAF or RAS mutations have poor outcomes. Cancer stem cells (CSCs) play central roles in drug resistance and CRC recurrence. Therefore, targeting the epigenetic mechanisms that sustai...
Saved in:
| Main Authors: | Maria Serena Roca, Rita Lombardi, Cristina Testa, Federica Iannelli, Laura Grumetti, Tania Moccia, Veronica Barile, Laura Addi, Domenico Memoli, Alessandra Leone, Simone Di Franco, Giorgio Stassi, Antonio Avallone, Francesca Bruzzese, Biagio Pucci, Alfredo Budillon, Elena Di Gennaro |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Publishing Group
2025-08-01
|
| Series: | Cell Death and Disease |
| Online Access: | https://doi.org/10.1038/s41419-025-07902-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
[Comment] Neoadjuvant chemotherapy with oxaliplatin and fluoropyrimidine versus upfront surgery for locally advanced colon cancer: the randomized, phase Ⅲ OPTICAL trial
by: Zhang Muzi
Published: (2024-06-01) -
Pharmacogenetic Testing for Fluoropyrimidines at Instituto Nacional de Câncer, Brazil
by: Guilherme Suarez-Kurtz
Published: (2025-01-01) -
Primary prevention of cardiotoxicity in cancer patients treated with fluoropyrimidines: a randomized controlled trial
by: Johanne D. Lyhne, et al.
Published: (2025-05-01) -
P677: Implementation of pharmacogenomic DPYD-guided fluoropyrimidine dosing for cancer patients in Saskatchewan, Canada
by: Yanwei Xi, et al.
Published: (2025-01-01) -
Oxaliplatin-Induced Lhermitte’s Sign in Gastric Cancer
by: Takeshi Okamoto, et al.
Published: (2020-01-01)